Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Oncology Therapeutics Inc.(BBOT) | 0 | 3,289,661 | +3,289,661 | 0 | 38,094 | 17.13% | +38,094 |
| Bicara Therapeutics Inc. | 2,204,650 | 2,204,650 | 0 | 20,481 | 34,811 | 15.66% | +14,330 |
| Kestra Med Technologies Ltd SHS | 1,645,893 | 1,645,893 | 0 | 27,289 | 39,106 | 17.59% | +11,818 |
| Nuvation Bio(NUVB) | 11,042,728 | 8,831,089 | -2,211,639 | 21,533 | 32,675 | 14.69% | +11,142 |
| Beta Bionics Inc.(BBNX) | 1,988,287 | 1,920,125 | -68,162 | 28,949 | 38,153 | 17.16% | +9,203 |
| ImageneBio, Inc.(IMA) | 0 | 455,361 | +455,361 | 0 | 3,711 | 1.67% | +3,711 |
| Upstream Bio Inc.(UPB) | 2,036,293 | 1,356,293 | -680,000 | 22,358 | 25,512 | 11.47% | +3,153 |
| enGene Holdings Inc. COM | 526,357 | 526,357 | 0 | 1,916 | 3,595 | 1.62% | +1,679 |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | 2,303 | 2,995 | 1.35% | +692 |
| Alumis Inc. | 653,223 | 653,223 | 0 | 1,960 | 2,606 | 1.17% | +647 |
| enGene Holdings Inc. *W EXP 10/31/202 | 321,502 | 89,702 | -231,800 | 273 | 63 | 0.03% | -210 |
| Immunic Inc.(IMUX) | 1,788,160 | 0 | -1,788,160 | 1,248 | 0 | — | -1,248 |
| Ikena Oncology | 2,249,123 | 0 | -2,249,123 | 3,014 | 0 | — | -3,014 |
| Lexeo Therapeutics(LXEO) | 1,184,636 | 0 | -1,184,636 | 4,762 | 0 | — | -4,762 |
| Replimune Group(REPL) | 1,975,203 | 248,672 | -1,726,531 | 18,350 | 1,042 | 0.47% | -17,308 |